Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP144989E

Novus Biologicals™ SESN2 Antibody Blocking Peptide
SDP

Catalog No. NBP144989E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.25 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP144989E 0.25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP144989E Supplier Novus Biologicals™ Supplier No. NBP144989PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A peptide corresponding to amino acids 1 - 55 of human SESN2. The SESN2 Blocking Peptide is derived from Synthetic. The SESN2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 83667
Species Human
Purification Method Affinity purified
Purity >85%, by HPLC
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-44989. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias DKFZp761M0212, DKFZp761M02121, Hi95, HI95sestrin-2, SES2, SEST2hypoxia induced gene 95, sestrin 2
Gene Symbol SESN2
Product Type SESN2
Quantity 0.25 mg
Regulatory Status RUO - research use only
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.